The country and blues singer has been openly battling a rare cancer, and he recently revealed that the disease has grown in ...
A new pancreatic cancer treatment targeting the KRAS gene mutation represents a major breakthrough, offering the first ...
Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than ...
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to ...
South Korean researchers have developed a new antibody capable of precisely targeting mutations in hard-to-treat cancers — ...
The tumour microenvironment also makes pancreatic cancer highly resistant to treatment. The tumour is surrounded by dense ...
Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have ...
New KRAS-targeting drug for metastatic pancreatic cancer nearly doubles second-line survival; expert explains impact, side effects, next trials.
Background New-onset diabetes (NOD) increases the risk of pancreatic cancer. Previous studies have mainly focused on the ...
Sita Kugel, PhD, is the inaugural recipient of the Leung Roy Family Endowed Chair. She investigates the molecular drivers of cancer and looks for ways to target them with small molecules and ...
A phase 2 clinical trial published in the European Journal of Cancer suggests that a novel form of focused ultrasound combined with standard FOLFIRINOX chemotherapy may improve tumor response and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results